CEFUROXIME (cefuroxime axetil)
BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+24
RISING PHARM
Indication
Staphylococcus aureus skin and skin structure infection
A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues. Read more about Staphylococcus aureus skin and skin structure infection
877 drugs 217 manufacturers
Drugs that treat it
Common Staphylococcus aureus skin and skin structure infection therapies.
AUGMENTIN (amoxicillin/potassium clavulanate)
ACUTE BACTERIAL OTITIS MEDIA·+19
NEOPHARMA INC
CLARITHROMYCIN
MACROLIDE ANTIBIOTICS·DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION·+28
RISING PHARM
CEFPROZIL
BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+12
RISING PHARM
CEFPROZIL
BETA-LACTAMS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+12
RISING PHARM
CEFUROXIME SODIUM
BETA-LACTAMS·STREPTOCOCCAL SEPTICEMIA·+30
Hikma Pharmaceuticals USA
CEFUROXIME SODIUM
BETA-LACTAMS·STREPTOCOCCAL SEPTICEMIA·+30
Hikma Pharmaceuticals USA
CEFEPIME HCL
FEBRILE NEUTROPENIC PATIENT PRESUMED INFECTION TREATMENT·+26
MEITHEAL PHARMA
CEFEPIME HCL
BETA-LACTAMS·FEBRILE NEUTROPENIC PATIENT PRESUMED INFECTION TREATMENT·+26
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Staphylococcus aureus skin and skin structure infection preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues.
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response.
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation.
Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia.
- fda.gov
A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues
- nih.gov
A *Staphylococcus aureus* skin and skin structure infection is a bacterial infectious condition involving the integumentary system, including the epidermis, dermis, and deeper subcutaneous tissues
- fda.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
- nih.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
- nih.gov
It occurs across both pediatric and adult populations when pathogenic *Staphylococcus aureus* breaches the cutaneous barrier, utilizing surface adhesins, enzymes, and cytolytic exotoxins to induce localized tissue damage and an intense inflammatory response
- nih.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation
- cdc.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia
- nih.gov
Clinically, these infections frequently manifest as purulent lesions—ranging from folliculitis, furuncles, carbuncles, and cutaneous abscesses to purulent cellulitis and infected wounds—characterized by localized erythema, edema, warmth, pain, and pus accumulation
- fda.gov
Without timely therapeutic control, the infection can progress to extensive tissue necrosis or disseminate hematogenously, resulting in invasive systemic complications such as bacteremia
Personalize your experience
Follow Staphylococcus aureus skin and skin structure infection and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.